P16ink4a inactivation contributes less than P19arf (the murine counterpart of human P14ARF) inactivation to cancer development in mice, while P16INK4A inactivation contributes more than P14ARF inactivation to cancer development in humans (39, 40). This evidence concerns the gene CDKN2A and cancer.